ICYMI: Study Finds Telehealth Key to Helping Pediatric Type 1 Diabetes Patients Manage Their Health

Virtual Care and Digital Solutions Supported Consistent Disease Management During the COVID-19 Pandemic

In case you missed it, a recent study conducted by BMC Pediatrics highlights how telehealth played a key role in assisting pediatric patients with Type 1 diabetes to manage their health during the COVID-19 pandemic.

The study, which analyzed 1,600 pediatric patients living with Type 1 diabetes, reveals that in the time before and after the COVID-19 pandemic, there was no difference in factors such as glycemic control, glucose monitoring, and patient characteristics when comparing groups of patients surveyed before and after the pandemic changed health system operations — in large part due to increased usage of telehealth solutions.

“Increased adoption of continuous glucose monitors and extensive use of telemedicine visits may have ameliorated the impact of the pandemic on disease management,” the study authors note. “Rapid adoption of telemedicine, improved access to CGM and, perhaps, increased parental oversight of diabetes care likely helped maintain glycemic control and hospitalization frequencies at pre-pandemic levels.” 

Read coverage of the study in mHealthIntelligence HERE.

Read the full study from BMC HERE. 

Learn more about how Congress can act to permanently protect telehealth access HERE.

ABOUT TELEHEALTH ACCESS FOR AMERICA

Telehealth Access for America (TAFA) is a public education campaign supported by leaders in health care committed to better care, expanded patient choice, and protecting access to critical telehealth services. Learn more and take action today at www.telehealthaccessforamerica.org.